EP3996663B1 - Hair care composition comprising antidandruff agent - Google Patents
Hair care composition comprising antidandruff agent Download PDFInfo
- Publication number
- EP3996663B1 EP3996663B1 EP20733316.2A EP20733316A EP3996663B1 EP 3996663 B1 EP3996663 B1 EP 3996663B1 EP 20733316 A EP20733316 A EP 20733316A EP 3996663 B1 EP3996663 B1 EP 3996663B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- wax
- composite particle
- antidandruff agent
- substance
- cationic polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title description 78
- 239000003795 chemical substances by application Substances 0.000 claims description 45
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical group NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims description 39
- 239000001993 wax Substances 0.000 claims description 34
- -1 trimethylammonioethyl Chemical group 0.000 claims description 32
- 239000011246 composite particle Substances 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 29
- 229920006317 cationic polymer Polymers 0.000 claims description 27
- 229920001661 Chitosan Polymers 0.000 claims description 25
- 239000002245 particle Substances 0.000 claims description 22
- 239000002002 slurry Substances 0.000 claims description 18
- 229920001577 copolymer Polymers 0.000 claims description 17
- 239000006184 cosolvent Substances 0.000 claims description 11
- 229920001519 homopolymer Polymers 0.000 claims description 11
- BGTBFNDXYDYBEY-FNORWQNLSA-N 4-(2,6,6-Trimethylcyclohex-1-enyl)but-2-en-4-one Chemical compound C\C=C\C(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-FNORWQNLSA-N 0.000 claims description 9
- 229940081510 piroctone olamine Drugs 0.000 claims description 8
- 235000013871 bee wax Nutrition 0.000 claims description 7
- 239000012166 beeswax Substances 0.000 claims description 7
- 150000002191 fatty alcohols Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 239000004204 candelilla wax Substances 0.000 claims description 5
- 235000013868 candelilla wax Nutrition 0.000 claims description 5
- 229940073532 candelilla wax Drugs 0.000 claims description 5
- 239000004203 carnauba wax Substances 0.000 claims description 5
- 235000013869 carnauba wax Nutrition 0.000 claims description 5
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims description 5
- 150000002576 ketones Chemical group 0.000 claims description 5
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 claims description 4
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 claims description 4
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 claims description 4
- ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 2-octanone Chemical compound CCCCCCC(C)=O ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004166 Lanolin Substances 0.000 claims description 4
- 239000012179 bayberry wax Substances 0.000 claims description 4
- 239000012185 ceresin wax Substances 0.000 claims description 4
- 239000012174 chinese wax Substances 0.000 claims description 4
- 239000012183 esparto wax Substances 0.000 claims description 4
- 239000012182 japan wax Substances 0.000 claims description 4
- 235000019388 lanolin Nutrition 0.000 claims description 4
- 229940039717 lanolin Drugs 0.000 claims description 4
- 239000012170 montan wax Substances 0.000 claims description 4
- 239000012168 ouricury wax Substances 0.000 claims description 4
- 239000012186 ozocerite Substances 0.000 claims description 4
- 239000012187 peat wax Substances 0.000 claims description 4
- 239000004170 rice bran wax Substances 0.000 claims description 4
- 235000019384 rice bran wax Nutrition 0.000 claims description 4
- 239000012176 shellac wax Substances 0.000 claims description 4
- 239000012180 soy wax Substances 0.000 claims description 4
- 239000012177 spermaceti Substances 0.000 claims description 4
- 229940084106 spermaceti Drugs 0.000 claims description 4
- 239000012181 tallow tree wax Substances 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- 229920002873 Polyethylenimine Polymers 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 108010039918 Polylysine Proteins 0.000 claims description 2
- 102000007327 Protamines Human genes 0.000 claims description 2
- 108010007568 Protamines Proteins 0.000 claims description 2
- 229920002472 Starch Chemical class 0.000 claims description 2
- 150000002118 epoxides Chemical class 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 229920000768 polyamine Polymers 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229940048914 protamine Drugs 0.000 claims description 2
- 239000008107 starch Chemical class 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000000047 product Substances 0.000 description 38
- 229950001046 piroctone Drugs 0.000 description 31
- 239000002453 shampoo Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 28
- 239000011859 microparticle Substances 0.000 description 25
- 229920000642 polymer Polymers 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 125000002091 cationic group Chemical group 0.000 description 18
- 230000008021 deposition Effects 0.000 description 17
- 239000000178 monomer Substances 0.000 description 17
- 229920001296 polysiloxane Polymers 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 210000004761 scalp Anatomy 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- 238000004811 liquid chromatography Methods 0.000 description 9
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 9
- 239000002131 composite material Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 244000303965 Cyamopsis psoralioides Species 0.000 description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 7
- 229920003086 cellulose ether Polymers 0.000 description 7
- 229940082500 cetostearyl alcohol Drugs 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 239000000516 sunscreening agent Substances 0.000 description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 5
- 239000008406 cosmetic ingredient Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000005152 nicotinamide Nutrition 0.000 description 5
- 239000011570 nicotinamide Substances 0.000 description 5
- 229960003966 nicotinamide Drugs 0.000 description 5
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 5
- 239000006254 rheological additive Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 150000003751 zinc Chemical class 0.000 description 5
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 4
- 241000282372 Panthera onca Species 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 229920013820 alkyl cellulose Polymers 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 239000012876 carrier material Substances 0.000 description 4
- 150000001991 dicarboxylic acids Chemical class 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 150000008195 galaktosides Chemical group 0.000 description 4
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 3
- OMWSZDODENFLSV-UHFFFAOYSA-N (5-chloro-2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 OMWSZDODENFLSV-UHFFFAOYSA-N 0.000 description 3
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 229960003344 climbazole Drugs 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 150000008146 mannosides Chemical group 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical class CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 229920000289 Polyquaternium Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960004697 enzacamene Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 150000002763 monocarboxylic acids Chemical class 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000003141 primary amines Chemical group 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 2
- 229960002026 pyrithione Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003335 secondary amines Chemical group 0.000 description 2
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003512 tertiary amines Chemical group 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AQSGIPQBQYCRLQ-UHFFFAOYSA-N (6,6-dihydroxy-4-methoxycyclohexa-2,4-dien-1-yl)-phenylmethanone Chemical compound C1=CC(OC)=CC(O)(O)C1C(=O)C1=CC=CC=C1 AQSGIPQBQYCRLQ-UHFFFAOYSA-N 0.000 description 1
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- JHDBMHFWQRTXLV-UHFFFAOYSA-N 1-dodecoxydodecane;2-sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC JHDBMHFWQRTXLV-UHFFFAOYSA-N 0.000 description 1
- UDJZTGMLYITLIQ-UHFFFAOYSA-N 1-ethenylpyrrolidine Chemical compound C=CN1CCCC1 UDJZTGMLYITLIQ-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 1
- GLJADRYELJNXDG-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;zinc Chemical compound [Zn].OC(=O)N1CCCC1=O GLJADRYELJNXDG-UHFFFAOYSA-N 0.000 description 1
- KSLINXQJWRKPET-UHFFFAOYSA-N 3-ethenyloxepan-2-one Chemical compound C=CC1CCCCOC1=O KSLINXQJWRKPET-UHFFFAOYSA-N 0.000 description 1
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 1
- AYKYXWQEBUNJCN-UHFFFAOYSA-N 3-methylfuran-2,5-dione Chemical compound CC1=CC(=O)OC1=O AYKYXWQEBUNJCN-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 240000006304 Brachychiton acerifolius Species 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical group OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000230012 Gleditsia triacanthos Species 0.000 description 1
- 235000013813 Gleditsia triacanthos Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102220549062 Low molecular weight phosphotyrosine protein phosphatase_C13S_mutation Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000555676 Malassezia Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- VEPKQEUBKLEPRA-UHFFFAOYSA-N VX-745 Chemical compound FC1=CC(F)=CC=C1SC1=NN2C=NC(=O)C(C=3C(=CC=CC=3Cl)Cl)=C2C=C1 VEPKQEUBKLEPRA-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000003550 alpha-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004103 aminoalkyl group Chemical class 0.000 description 1
- 229920013822 aminosilicone Polymers 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- NKHAVTQWNUWKEO-UHFFFAOYSA-N fumaric acid monomethyl ester Natural products COC(=O)C=CC(O)=O NKHAVTQWNUWKEO-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000002535 lyotropic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- SOXAGEOHPCXXIO-UHFFFAOYSA-N meradimate Chemical compound CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-UHFFFAOYSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 229950000999 mexenone Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- NKHAVTQWNUWKEO-NSCUHMNNSA-N monomethyl fumarate Chemical compound COC(=O)\C=C\C(O)=O NKHAVTQWNUWKEO-NSCUHMNNSA-N 0.000 description 1
- 229940005650 monomethyl fumarate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229950002083 octabenzone Drugs 0.000 description 1
- FSAJWMJJORKPKS-UHFFFAOYSA-N octadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C=C FSAJWMJJORKPKS-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 229940095673 shampoo product Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 229940043825 zinc carbonate Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 229940071566 zinc glycinate Drugs 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical class [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Definitions
- the present invention relates to hair care compositions that comprise an antidandruff agent, more particularly piroctone olamine.
- an antidandruff shampoo or conditioner depends largely on the amount of the antidandruff agent deposited on the scalp and hair.
- the contact time of hair/scalp with any wash-off haircare product is very short e.g., 10 to 120 seconds after which the composition gets washed off, so the antidandruff agent may not get enough time for deposition. Therefore, in the limited time of contact, it is desirable to deposit as much of the agent as possible.
- deposition of any active ingredient, especially antidandruff agent, through a wash-off haircare composition presents a technical problem because some amount of the particles of the antidandruff agent tend to wash off rather than deposit. To offset the loss, an increase in the amount of the antidandruff agent is a possible solution but it is neither technically sound nor economically viable.
- Piroctone olamine (Octopirox ® ) is a widely used antidandruff agent.
- insufficient deposition remains a technical problem.
- Another problem is instability in shampoos.
- US20040213751 A1 discloses a haircare composition comprising pyrithione and a zinc-containing layered material which provides an augmentation factor greater than 1.
- WO14124066 A1 discloses hair care compositions comprising cationic polymers and anionic particulates for improved deposition of pyrithione.
- WO2008101546 discloses a cosmetic preparation with an active ingredient for the protection or treatment of the skin and / or the hair and with a carrier material in or to which the active ingredient is bound or associated with the active ingredient, wherein the carrier material comprises a proportion of chitosan.
- the active substance is bound with or is associated with a carrier material is a fraction having chitosan and a proportion of polylactide, polyglycolide and / or polylactide glycolide or derivatives thereof, and wherein the carrier material is in the form of particles having an average particle size of 10 to 1000 nm.
- WO10105922 A1 discloses a particle comprising a waxy solid and a polymeric deposition aid having no overall cationic charge and a method to prepare such particle.
- WO9823258 A1 discloses a shampoo containing piroctone olamine and 0.1 to 5 % by weight polyethylenimine to enhance the deposition of piroctone olamine.
- a composite particle comprising:
- particles of the invention not only serve to deposit more of the antidandruff agent on the scalp but also stabilise the antidandruff agent, especially piroctone olamine, in a haircare product, such as a shampoo composition.
- Such agents may lose their efficacy over a period presumably due to presence of surfactants, polymers and other ingredients which may degrade or destabilize the antidandruff agent.
- a method of preparing a composition as claimed in claim 1 comprising a step of heating and agitating an aqueous slurry comprising said wax or wax-like substance and said antidandruff agent, followed by a step of adding said cationic polymer to said slurry and further heating said slurry for 5 to 60 minutes at 30 to 100 °C.
- a hair care product comprising a composition of the first aspect.
- any feature of one aspect of the present invention may be utilized in any other aspect of the invention.
- the word “comprising” is intended to mean “including” but not necessarily “consisting of or “composed of.” In other words, the listed steps or options need not be exhaustive. It is noted that the examples given in the description below are intended to clarify the invention and are not intended to limit the invention to those examples per se. Similarly, all percentages are weight/weight percentages unless otherwise indicated. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description and claims indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about”.
- Numerical ranges expressed in the format “from x to y” are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format “from x to y", it is understood that all ranges combining the different endpoints are also contemplated.
- the indefinite article “a” or “an” and its corresponding definite article “the” means at least one, or one or more, unless specified otherwise.
- the various features of the present invention referred to in individual sections above apply, as appropriate, to other sections mutatis mutandis. Consequently, features specified in one section may be combined with features specified in other sections as appropriate. Any section headings are added for convenience only and are not intended to limit the disclosure in any way.
- haircare product is meant to include a composition for topical application to hair or scalp of mammals, especially humans.
- topical is meant that the product is applied to the external surface of the body. In the present invention this is achieved by applying the haircare product to hair or scalp.
- a product may be generally classified as leave-on or rinse off, and includes any product applied for improving the appearance, cleansing, odor control or general aesthetics of scalp and hair.
- the haircare product of the present invention is preferably a leave-on product.
- the haircare product of the present invention is a wash-off composition.
- a haircare product in accordance with the present invention is preferably a shampoo, hair conditioner, hair cream, hair colour, hair serum, mousse, hair gel or hair oil.
- the composite particle of the invention comprises:
- particles means particles ranging in size from 0.1 to 1000 ⁇ m, preferably from 0.1 to 100 ⁇ m, most preferably from 1 to 50 ⁇ m.
- the composition of the invention is powdery.
- the composition of the invention i.e., the particles is powdery, preferably a freeze-dried powder.
- the size may be measured for example, by laser diffraction using a system (such as a Mastersizer TM 2000 available from Malvern Instruments Ltd). It is preferred that ratio of the amount of the antidandruff agent to the amount of said wax or wax-like substance in said microparticles is from 1:0.01 to 1:1000 parts by weight.
- microparticles comprise 0.1 to 80 wt% antidandruff agent, 18 to 95 wt% of the wax or wax-like substance and 0.5 to 10 wt% cationic polymer.
- Wax or wax-like substance Wax or wax-like substance
- composition of this invention comprises a wax or a wax-like substance in which the antidandruff agent is soluble or dispersible, where melting point of the wax and the substance is 30°C to 105°C.
- the wax-like substance is not a UV absorbing sunscreen.
- Melting point refers to the temperature at which the solid and liquid forms of a pure substance can exist in equilibrium.
- the wax of the invention is at least one of beeswax, Chinese wax, lanolin, shellac wax, spermaceti, bayberry wax, candelilla wax, carnauba wax, castor wax, esparto wax, Japan wax, ouricury wax, rice bran wax, soy wax, tallow tree wax, ceresin wax, montan wax, ozocerite or peat wax.
- Such waxes are often selected from hydrocarbon waxes and ester waxes, that can be derived from natural sources or synthesized. Suitable hydrocarbon waxes include mineral wax, microcrystalline wax, Montana wax, and low molecular weight polyethylene, such as from 300 to 600 daltons.
- Suitable ester waxes can be derived from unsaturated natural oils, such as plant-originating triglyceride oils by hydrogenation and optionally dehydroxylation (where the substituent contains at least one hydroxyl group as in castor oil).
- Suitable ester waxes include caster wax, candelilla wax, carnauba wax, beeswax and spermeceti wax.
- Natural waxes such as beeswax include a range of different chemical classes. Synthetic esters often comprise aliphatic monoesters containing at least 30 carbons, and indeed may be isolated natural products such as beeswax, or be derived from them or be the same compounds.
- the wax-like substance of the present invention is a C13-35 fatty alcohol.
- fatty alcohols include cetostearyl alcohol, cetyl alcohol, stearyl alcohol, eicosyl alcohol and behenyl alcohol.
- the wax and the wax-like substance is not a UV absorbing sunscreen.
- sunscreens are listed below: 2-hydroxy-4-methoxybenzophenone (also named as Benzophenone-3 CAS: 131-57-7 , MP 62 to 64°C), 2,2-dihydroxy-4-methoxybenzophenone ( CAS: 131-53-3 , MP 73 to 75°C), butylmethoxydibenzoylmethane ( CAS: 70356-09-1 , MP 81 to 84°C), bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S, CAS: 187393-00-6 , MP 83-85°C), Menthyl anthranilate ( CAS: 134-09-8 , MP 62.5-63.5°C), 4-Methylbenzylidene camphor (Enzacamene) ( CAS: 36861-47-9 , MP 66 to 69°C), Benzophenone-7 (5
- composition of the invention i.e., the microparticles, preferably comprise from 0.1 to 80 wt.%, preferably from 0.2 to 40 wt.%, more preferably from 0.25 to 15 wt.% of the antidandruff agent.
- Antidandruff agents are compounds that are active against dandruff and are typically antimicrobial agents, preferably antifungal agents. Antidandruff agents typically display a minimum inhibitory concentration of about 50 mg/ml or less against Malassezia.
- the anti-dandruff agent is piroctone olamine, climbazole, selenium sulphide, zinc pyrithione, or zinc sulfate.
- compositions of the invention also comprise a cationic polymer.
- the polymer is polyamine, polyvinylpyrrolidone, polylysine, protamine, trimethylammonioethyl (meth)acrylate homopolymer and copolymer, acrylamidopropyl trimethylammonium halide homopolymer and copolymer, dialkyldiallylammonium halide homopolymer and copolymer, chitosan or derivatized chitosan, cellulose derivatives comprising trimethyl ammonium substituted epoxide, starch hydroxypropyl trimethyl ammonium halide, polyethyleneimines or polycondensates containing diquaternary ammonium or polyquaternary ammonium repeating units.
- cationic polymer is used to distinguish such polymers from anionic, i.e., negatively charged polymers as well as from non-ionic polymers, i.e., polymers devoid of any charge.
- molecular weight of the cationic polymer is 30,000 to 1,000,000 Daltons, more preferably from 70,000 to 600,000 Daltons, and still even more preferably from 150,000 to 400,000 Daltons.
- Zeta potential is the charge that develops at the interface between a solid surface and its liquid medium. This potential, which is measured in Millivolts, may arise by any of several mechanisms. Among these are the dissociation of ionogenic groups in the particle surface and the differential adsorption of solution ions into the surface region. The net charge at the particle surface affects the ion distribution in the nearby region, increasing the concentration of counterions close to the surface. Thus, an electrical double layer is formed in the region of the particle-liquid interface. Zeta potential is therefore a function of the surface charge of the particle, any adsorbed layer at the interface, and the nature and composition of the surrounding suspension medium.
- the zeta potential has proven to be extremely relevant to the practical study and control of colloidal stability and flocculation processes.
- a variety of methods and apparatus are available for its measurement with a reasonable degree of precision.
- the zeta potential of the particles is measured using a Malvern Nano ZS90 apparatus, in DI water at a solid content of 50 ppm and pH of 7 at 25°C.
- zeta potential of the cationic polymer is from +10 to +100 mV. It is particularly preferred that the polymer is chitosan. It is preferred that the chitosan comprises a chitosan component and an anion. It is preferred that the chitosan is a salt of chitosan and an amino acid. Preferably the amino acid comprises glutamine, glutamic acid, histidine, leucine, lysine, serine, threonine, arginine or a mixture thereof, more preferably arginine.
- the chitosan comprises at least 5%, more preferably at least 10% of protonated primary amino group by mole of the total amount of primary amino group and protonated primary amino group.
- degree of deacetylation of chitosan is at least 65%, more preferably from 70 to 95%, even more preferably from 72 to 90% and most preferably from 75 to 85%.
- ratio of the antidandruff agent to the cationic polymer in said microparticles is from 1:0.01 to 1:1000 parts by weight.
- compositions of the invention i.e., particles
- This co-solvent is in addition to the wax or wax-like substance.
- co-solvent is a ketone selected from 2-hexanone or 2-octanone or damascone.
- this ketone is damascone.
- a method of preparing a composition of the first aspect comprising a step of heating and agitating an aqueous slurry comprising said wax or wax-like substance and said antidandruff agent, followed by a step of adding said cationic polymer to said slurry and further heating said slurry for 5 to 60 minutes at 30 to 100 °C to get the composite particle or a slurry of the composite particle.
- a hair care product comprising a composition of the first aspect. More preferably the haircare product comprises an amount of the composition (i.e., microparticles) such that the total amount of the antidandruff agent in said haircare product is from 0.01 to 5.0 wt%.
- the haircare product is a shampoo, hair conditioner, hair cream, hair colour, hair serum, mousse, hair gel or hair oil.
- the haircare compositions in accordance with this invention may also comprise additional antidandruff agent which may, for example, be the same as the one contained inside the microparticles.
- the haircare compositions of the invention preferably comprise 0.05 to 5 wt% of additional antidandruff agent.
- the additional antidandruff agent is preferably selected from azoles, Octopirox ® (piroctone olamine), selenium sulfide, salicylic acid and combinations thereof. Azoles include ketoconazole and climbazole, preferably climbazole.
- the haircare compositions of the invention may further comprise a zinc salt.
- the additional zinc salt may suitably be selected from zinc salts of organic acids, zinc salts of inorganic acids, zinc oxides, zinc hydroxides or a mixture thereof.
- the haircare compositions of the invention comprise 0.1 to 5 wt%, preferably 0.2 to 3 wt%, more preferably from 0.25 to 2.5 wt% of the salt based on the total weight of the composition.
- the haircare compositions of the present invention comprises a surfactant selected from the group consisting of anionic surfactants, nonionic surfactants, zwitterionic surfactants and mixtures thereof. The nature, type, amount and specific combinations that may be used depend on the formulation of the composition and would largely depend on whether it is a shampoo or a conditioner or a conditioning shampoo.
- the haircare product of the invention is a shampoo.
- a surfactant which is sodium lauryl sulphate, sodium lauryl ether sulphate, sodium lauryl ether sulphosuccinate, ammonium lauryl sulphate, ammonium lauryl ether sulphate, sodium cocoyl isethionate and lauryl ether carboxylic acid, coco betaine, cocamidopropyl betaine, sodium cocoamphoacetate or a mixture thereof.
- the haircare product of the present invention comprises from 1 to 50%, preferably from 2 to 40%, more preferably from 4 to 25% total surfactant.
- the haircare product of the invention comprises a cosmetic ingredient.
- the cosmetic ingredient is selected from the group consisting of a silicone, an antibacterial agent other than antidandruff agents, a foam booster, a perfume, encapsulates (for example encapsulated fragrance) a dye, a colouring agent, a pigment, a preservative, a thickener, a protein, a phosphate ester, a buffering agent, a pH adjusting agent, a pearlescer (for example; mica, titanium dioxide, titanium dioxide coated mica, ethylene glycol distearate (INCI glycol distearate)) and/or opacifier, a viscosity modifier, an emollient, a sunscreen, an emulsifier, a sensate active (for example menthol and menthol derivatives), vitamins, mineral oils, essential oils, lipids, natural actives, glycerin, natural hair nutrients such as botanical extracts, fruit extracts, sugar derivatives and amino acids, micro
- the haircare product of the present invention includes from 0.01 to 20 wt% of the at least one cosmetic ingredient, more preferably from 0.05 to 10 wt%, still more preferably from 0.075 to 7.5 wt% and most preferably, from 0.1 to 5 wt% of the at least one cosmetic ingredient, by weight of the total product.
- the haircare product of the present invention may also comprise synergistic antimicrobial compounds that give synergistic antimicrobial benefit when used in combination with the antidandruff active (for example zinc pyrithione) to enhance its properties and further inhibit the growth of Malassezia furfur.
- synergistic antimicrobial compounds include compounds having alcoholic groups (e.g. honokiol, magnolol or paeonol), Piperazines and a phenolic compound found in natural plant extract viz. thymol and terpeniol.
- the haircare product may additionally comprise a vitamin B3 compound.
- the preferred vitamin B3 compound is niacinamide.
- Niacinamide is known for secretion of AMPs (Anti-Microbial Proteins) from keratinocytes.
- the AMPs thus secreted provides for improving immunity of e.g. the scalp.
- the anti-dandruff efficacy can be enhanced not just through anti-fungal activity but by boosting the scalp's own protection shield against germs, through use of niacinamide. This combination could provide further long-lasting protection e.g. up to 24 hours of protection against germs.
- the haircare compositions of the invention comprise 0.1 to 5% niacinamide, more preferably 0.5 to 5%, furthermore preferably 0.5 to 3%, and optimally 1.0 to 3.0% by weight of the composition.
- the haircare product of the invention comprises silicone.
- compositions of the invention may contain emulsified droplets of a silicone conditioning agent for enhancing conditioning performance.
- Suitable silicones include polydiorganosiloxanes, polydimethylsiloxanes which have the CTFA designation dimethicone.
- suitable for use in the compositions of the invention are polydimethyl siloxanes having hydroxyl end groups, which have the CTFA designation dimethiconol.
- the viscosity of the emulsified silicone is at least 10,000 cst at 25 °C, the viscosity of the silicone is preferably at least 60,000 cst, most preferably at least 500,000 cst, ideally at least 1,000,000 cst. Preferably the viscosity does not exceed 10 9 cst for ease of formulation.
- Suitable pre-formed emulsions include Xiameter MEM 1785 and microemulsion DC2-1865 available from Dow Corning. These are emulsions /microemulsions of dimethiconol. Cross-linked silicone gums are also available in a pre-emulsified form, which is advantageous for ease of formulation.
- a further preferred class of silicones for inclusion in shampoos and conditioners are amino functional silicones.
- amino functional silicone is meant a silicone containing at least one primary, secondary or tertiary amine group, or a quaternary ammonium group.
- suitable amino functional silicones include: polysiloxanes having the CTFA designation "amodimethicone”.
- amino functional silicones suitable for use in the invention are the aminosilicone oils DC2-8220, DC2-8166 and DC2-8566 (all ex Dow Corning).
- the total amount of silicone is 0.01 to 10 %wt, more preferably 0.1 to 5 wt% and most preferably 0.5 to 3 wt%.
- pH of the haircare product of the present invention is preferably from 3 to 7, more preferably 4 to 7, even more preferably 4 to 6.5, most preferably from 4.2 to 6.5.
- the haircare product of the invention is a shampoo, it is generally aqueous, i.e. they have water or an aqueous solution or a lyotropic liquid crystalline phase as their major component.
- the shampoo composition comprises 50 to 98%, preferably from 60 to 92% water.
- the shampoo composition comprises one or more cationic polymers for conditioning the hair.
- Suitable cationic polymers include homopolymers which are cationically substituted or may be formed from two or more types of monomers.
- the weight average (M w ) molecular weight of the polymers will generally be between 100000 and 3 Million Daltons.
- the polymers will have cationic nitrogen containing groups such as quaternary ammonium or protonated amino groups, or a mixture thereof. If the molecular weight of the polymer is too low, then the conditioning effect is poor. If too high, then there may be problems of high extensional viscosity leading to stringiness of the composition when it is poured.
- the cationic nitrogen-containing group will generally be present as a substituent on a fraction of the total monomer units of the cationic polymer.
- the polymer when it is not a homopolymer it can contain spacer non-cationic monomer units.
- Such polymers are described in the CTFA Cosmetic Ingredient Directory, 3rd edition.
- the ratio of the cationic to non-cationic monomer units is selected to give polymers having a cationic charge density in the required range, which is generally from 0.2 to 3.0 meq/gm.
- the cationic charge density of the polymer is suitably determined via the Kjeldahl method as described in the US Pharmacopoeia under chemical tests for nitrogen determination.
- Suitable cationic polymers include copolymers of vinyl monomers having cationic amine or quaternary ammonium functionalities with water soluble spacer monomers such as (meth)acrylamide, alkyl and dialkyl (meth)acrylamides, alkyl (meth)acrylate, vinyl caprolactone and vinyl pyrrolidine.
- the alkyl and dialkyl substituted monomers preferably have C1-C7 alkyl groups, more preferably C1-3 alkyl groups.
- Other suitable spacers include vinyl esters, vinyl alcohol, maleic anhydride, propylene glycol and ethylene glycol.
- the cationic amines can be primary, secondary or tertiary amines, depending upon the particular species and the pH of the composition. In general, secondary and tertiary amines, especially tertiary, are preferred.
- Amine substituted vinyl monomers and amines can be polymerised in the amine form and then converted to ammonium by quaternization.
- the cationic polymers can comprise mixtures of monomer units derived from amine- and/or quaternary ammonium-substituted monomer and/or compatible spacer monomers.
- Suitable (non-limiting examples of) cationic polymers include:
- cationic polymers that can be used include cationic polysaccharide polymers, such as cationic cellulose derivatives, cationic starch derivatives, and cationic guar gum derivatives.
- a particularly suitable type of cationic polysaccharide polymer that can be used is a cationic guar gum derivative, such as guar hydroxypropyltrimethylammonium chloride (commercially available from Rhodia in their JAGUAR trademark series). Examples of such materials are JAGUAR C13S, JAGUAR C14 and JAGUAR C17.
- Mixtures of any of the above cationic polymers may be used.
- the haircare product of the invention comprises 0.01 to 5%, preferably from 0.02 to 1%, more preferably from 0.05 to 0.8% cationic polymer.
- the haircare product of the invention may additionally comprise a cationic deposition polymer which is a cationic polygalactomannans having an average molecular weight ( M w ) of from 1 million to 2.2 million g/mol and a cationic degree of substitution of from 0.13 to 0.3.
- a cationic deposition polymer which is a cationic polygalactomannans having an average molecular weight ( M w ) of from 1 million to 2.2 million g/mol and a cationic degree of substitution of from 0.13 to 0.3.
- the polygalactomannans are polysaccharides composed principally of galactose and mannose units and are usually found in the endosperm material of seeds from leguminous plants such as guar, locust bean, honey locust, flame tree, and other members of the Leguminosae family.
- Polygalactomannans are composed of a backbone of 1 ⁇ 4-linked ⁇ -D-mannopyranosyl main chain units (also termed mannoside units or residues) with recurring 1 ⁇ 6-linked ⁇ -D-galactosyl side groups (also termed galactoside units or residues) branching from the number 6 carbon atom of a mannopyranose residue in the polymer backbone.
- the polygalactomannans of the different Leguminosae species differ from one another in the frequency of the occurrence of the galactoside side units branching from the polymannoside backbone.
- the mannoside and galactoside units are generically referred to herein as glycoside units or residues.
- the average ratio of mannoside to galactoside units in the polygalactomannan contained in guar gum (hereinafter termed "guar") is approximately 2:1.
- Suitable cationic polygalactomannans include guar and hydroxyalkyl guar (for example hydroxyethyl guar or hydroxypropyl guar), that has been cationically modified by chemical reaction with one or more derivatizing agents.
- the amount of cationic polygalactomannans will generally range from about 0.05 to 1%, preferably from 0.1 to 0.8%, more preferably 0.2 to 0.6% by weight of the composition.
- the haircare product of the invention may additionally comprise an anionic polymeric rheology modifier such as a carboxylic acid polymer.
- carboxylic acid polymer in the context of this invention generally denotes a homopolymer or copolymer obtained from the polymerization of ethylenically unsaturated monomers containing pendant carboxylic acid groups (hereinafter termed “carboxylic monomers").
- Suitable carboxylic monomers generally have one or two carboxylic acid groups, one carbon to carbon double bond and contain a total of from 3 to about 10 carbon atoms, more preferably from 3 to about 5 carbon atoms.
- suitable carboxylic monomers include ⁇ - ⁇ -unsaturated monocarboxylic acids such as acrylic acid, methacrylic acid and crotonic acid; and ⁇ - ⁇ -unsaturated dicarboxylic acids such as itaconic acid, fumaric acid, maleic acid and aconitic acid. Salts, esters or anhydrides of the ⁇ - ⁇ -unsaturated mono- or dicarboxylic acids described above may also be used.
- Examples include half esters of ⁇ - ⁇ -unsaturated dicarboxylic acids with C 1-4 alkanols, such as monomethyl fumarate; cyclic anhydrides of ⁇ - ⁇ -unsaturated dicarboxylic acids such as maleic anhydride, itaconic anhydride and citraconic anhydride; and esters of acrylic acid or methacrylic acid with C 1-30 alkanols, such as ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, dodecyl acrylate, hexadecyl acrylate, and octadecyl acrylate.
- C 1-4 alkanols such as monomethyl fumarate
- cyclic anhydrides of ⁇ - ⁇ -unsaturated dicarboxylic acids such as maleic anhydride, itaconic anhydride and citraconic anhydride
- ethylenically unsaturated monomers can be copolymerized into the carboxylic acid polymer backbone.
- Example of such other ethylenically unsaturated monomers include styrene, vinyl acetate, ethylene, butadiene, acrylonitrile and mixtures thereof.
- Carboxylic acid polymers may preferably have a molecular weight of at least 1 million Daltons.
- Suitable examples include crosslinked copolymers polymerized from C 1-4 alkyl acrylate or methacrylate (e.g. ethyl acrylate) with one or more comonomers selected from acrylic acid, methacrylic acid and mixtures thereof. Such materials may generally be referred to under the INCI name of Acrylates Copolymer. Commercially available examples include Aculyn ® 33 from Rohm and Haas.
- crosslinked copolymers polymerized from C 10-30 alkyl esters of acrylic or methacrylic acid with one or more comonomers selected from acrylic acid, methacrylic acid and their respective C 1-4 alkyl esters.
- Such materials may generally be referred to under the INCI name of Acrylates/C 10-30 Alkyl Acrylate Crosspolymer.
- Commercially available examples include Carbopol ® polymers 1342 and 1382 from Lubrizol Advanced Materials.
- optionally crosslinked copolymers of acrylic acid or methacrylic acid with alkyl acrylates and ethoxylated hydrophobically modified alkyl acrylates are also suitable.
- Such materials may generally be referred to under the INCI names of Acrylates/Steareth-20 Methacrylate Copolymer, Acrylates/Beheneth-25 Methacrylate Copolymer, Acrylates/Steareth-20 Methacrylate Crosspolymer and Acrylates/Palmeth-25 Acrylates Copolymer.
- Commercially available examples include Aculyn ® 22, 28 or 88 from Rohm & Haas and Synthalen ® from 3V Sigma.
- the carboxylic acid is a Carbomer, such as homopolymers of acrylic acid crosslinked with an allyl ether of pentaerythritol or an allyl ether of sucrose.
- Mixtures of any of the aforementioned material may also be used.
- haircare product of the invention comprises 0.1 to 3.0%, more preferably 0.4 to 1.5% carboxylic acid polymer by weight of the composition.
- inorganic or organic bases include alkali metal hydroxides (e.g. sodium or potassium hydroxide), sodium carbonate, ammonium hydroxide, methylamine, diethylamine, trimethylamine, monoethanolamine, triethanolamine and mixtures thereof.
- the haircare product of the invention may also comprise a nonionic polymeric rheology modifier which is selected from one or more nonionic cellulose ethers.
- Suitable nonionic cellulose ethers or use as the nonionic polymeric rheology modifier in the invention include (C 1-3 alkyl) cellulose ethers, such as methyl cellulose and ethyl cellulose; hydroxy (C 1-3 alkyl) cellulose ethers, such as hydroxyethyl cellulose and hydroxypropyl cellulose; mixed hydroxy (C 1-3 alkyl) cellulose ethers, such as hydroxyethyl hydroxypropyl cellulose; and (C 1-3 alkyl) hydroxy (C 1-3 alkyl) cellulose ethers, such as hydroxyethyl methylcellulose and hydroxypropyl methylcellulose.
- Preferred nonionic cellulose ethers for use as the nonionic polymeric rheology modifier in the invention are water-soluble nonionic cellulose ethers such as methylcellulose and hydroxypropyl methylcellulose.
- water-soluble in this context denotes a solubility in water of at least 1 grams, more preferably at least 3 grams, most preferably at least 5 grams in 100 grams of distilled water at 25° C. and 1 atmosphere. This level indicates production of a macroscopically isotropic or transparent, coloured or colourless solution.
- Methyl cellulose and hydroxypropyl methylcellulose are commercially available in a number of viscosity grades from Dow Chemical as their METHOCEL ® trademark series.
- nonionic cellulose ethers may also be suitable.
- the level of nonionic cellulose ethers will generally range from about 0.01 to about 2.0%, and preferably ranges from 0.1 to 0.5%, more preferably from 0.1 to 0.3%, by weight based on the total weight of the composition.
- the haircare product of the invention comprises 0.1 to 0.3% by weight nonionic cellulose ether.
- the haircare product of the invention may contain further optional ingredients to enhance performance and/or consumer acceptability.
- additional optional ingredients include fragrance, dyes and pigments and preservatives.
- fragrance e.g., benzyl alcohol, benzyl ether, benzyl ether, benzyl ether, benzyl ether, benzyl ether, benzyl ether, benzyl ether sulfate, benzyl, sorbiol, sorbiol, sorbiol, sorbiol, sorbiol, sorbiol, sorbiol, sorbiol, sorbiol, sulfate, benzyl sulfate, benzyl sulfate, benzyl sulfate, benzyl sulfate, benzyl sulfate, benzyl sulfate, benzyl sulfate, benzyl sulfate
- the haircare product of the invention is primarily intended for topical application to hair and scalp.
- the haircare product When the haircare product is a shampoo, it is topically applied to the hair and then massaged into the hair and scalp. Then it is rinsed with water prior to drying the hair.
- a hair oil or hair serum, being leave-on haircare compositions, are left on for 1 to 10 hours after application before being washed off.
- Example 1 Preparation of a composition (microparticles) outside the invention (Ref.1)
- chitosan Three grams chitosan was dissolved in 300 mL of 0.5% aqueous acetic acid to form 1% chitosan solution. A gram of Octopirox ® was dissolved in 12.5 g molten cetostearyl alcohol to form a clear solution at 70°C.
- a 1% solution of chitosan acetate was prepared as disclosed earlier.
- a gram of Octopirox ® was dissolved in 12.5 g molten cetostearyl alcohol and 4 g damascone to form a clear solution at 70°C.
- the particle size of the microparticles was 43 ⁇ m.
- a 1% solution of chitosan acetate was prepared as disclosed earlier.
- a gram of Octopirox ® was dissolved in 8.5 g molten cetostearyl alcohol and 4 g damascone to form a clear solution at 70°C.
- compositions of Examples 1 to 4 were subjected to a variety of tests which are described hereinafter.
- Example 2 Ingredients/wt% Example Reference No. 1A 2A 3A 4A 5 Octopirox ® - - - - 0.2 Example 1 20 - - - - Example 2 - 20 - - - Example 3 - - 20 - - Example 4 - - - 20 - SLES (70%) 17.0 CAPB (30%) 5.0 Sodium chloride 1.0
- the extent of deposition of Octopirox ® on the scalp was determined as follows: A piece of model skin (2cm x 2cm x 4mm) was placed in a Petridish ® , to which 375 mg of the concerned shampoo (under evaluation) has been added. That piece and another blank piece (untreated) were then immersed in 10 ml methanol and dispersed with 10 minutes of ultrasonic treatment. An ml of the methanolic solution was passed through a 0.2 ⁇ m PTFE filter and transferred into Liquid Chromatography (LC) sample vial for LC analysis to get deposition amount data D 0 .
- LC Liquid Chromatography
- a piece of model skin (2cm x 2cm x 4mm) was placed in a Petridish ® , to which 375 mg of the concerned shampoo (under evaluation) has been added. That piece of shampoo on it was then gently rubbed with another piece (untreated) for 30 seconds and the two pieces were rinsed by 250 mL water. The rinsed pieces were then immersed in 10 ml methanol and dispersed with 10 minutes of ultrasonic treatment. An ml of the methanolic solution was passed through a 0.2 ⁇ m PTFE filter and transferred into Liquid Chromatography (LC) sample vial for LC analysis to get deposition amount data D.
- LC Liquid Chromatography
- the objective of this experiment was to determine the extent of stability of Octopirox ® contained in the microparticles of Examples 1 to 4 in a shampoo composition. It was evaluated by checking how much Octopirox ® contained within the microparticles leaked into the shampoo base. For this test the shampoo products 5 and 1A to 4A were used immediately after preparation. The test was repeated after storing the compositions for 1 day, 7 days and 14 days.
- the shampoo products were made by mixing four grams of the slurry of the microparticles (Example 1 to 4 as the case may be) with 16 g of a shampoo base in 50 mL centrifuge tubes. Therefore, the formulations of the shampoos for the purpose of this experiment were different from the formulations (1A to 4A) disclosed in Table 2. To avoid confusion with nomenclature, the sample reference numbers used for this experiment were labelled as 1B to 4B.
- Example 4 the slurry of Example 4 was freeze-dried to get a powder. Seven (7) mg of this powder was incubated in 2 mL of a model sebum composition in an oven maintained at 32°C. At a predetermined time, the mixture was taken out of the oven and passed through a 0.2 ⁇ m PTFE filter to remove any insoluble matter. The filtrate was dispersed in methanol and transferred into a LC sample vial for LC analysis. Another 7 mg of the same powder was dissolved directly in methanol and the concentration of Octopirox ® was measured by LC. This sample was for comparative purpose (control) and was for 100% release sample. Then the percentage of Octopirox ® getting released from the composite was calculated.
- a 1% solution of chitosan acetate was prepared as disclosed earlier.
- a gram of Octopirox ® was dissolved in 8.5 g molten lauryl alcohol (MP 24°C) and 4 g damascone to form a clear solution at 40°C.
- Octopirox ® A gram of Octopirox ® was dissolved in 8.5 g molten Fischer-Tropsch wax (Sasolwax ® H1, MP 112°C) and 4 g damascone to form a clear solution at 120°C.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Description
- The present invention relates to hair care compositions that comprise an antidandruff agent, more particularly piroctone olamine.
- The efficacy of an antidandruff shampoo or conditioner depends largely on the amount of the antidandruff agent deposited on the scalp and hair. Usually, at the point of use, the contact time of hair/scalp with any wash-off haircare product is very short e.g., 10 to 120 seconds after which the composition gets washed off, so the antidandruff agent may not get enough time for deposition. Therefore, in the limited time of contact, it is desirable to deposit as much of the agent as possible. However, deposition of any active ingredient, especially antidandruff agent, through a wash-off haircare composition presents a technical problem because some amount of the particles of the antidandruff agent tend to wash off rather than deposit. To offset the loss, an increase in the amount of the antidandruff agent is a possible solution but it is neither technically sound nor economically viable.
- Piroctone olamine (Octopirox®) is a widely used antidandruff agent. However, insufficient deposition remains a technical problem. Another problem is instability in shampoos.
-
US20040213751 A1 (P&G) discloses a haircare composition comprising pyrithione and a zinc-containing layered material which provides an augmentation factor greater than 1. -
WO14124066 A1 (P&G) -
WO2008101546 (Rovi) discloses a cosmetic preparation with an active ingredient for the protection or treatment of the skin and / or the hair and with a carrier material in or to which the active ingredient is bound or associated with the active ingredient, wherein the carrier material comprises a proportion of chitosan. The active substance is bound with or is associated with a carrier material is a fraction having chitosan and a proportion of polylactide, polyglycolide and / or polylactide glycolide or derivatives thereof, and wherein the carrier material is in the form of particles having an average particle size of 10 to 1000 nm. -
WO10105922 A1 [Unilever] - Our co-pending
application EP19154998 (Unilever) -
WO9823258 A1 (Unilever) - It has been determined that at least some of the problems of prior art can be solved by way of the present invention.
- In accordance with a first aspect is disclosed a composite particle comprising:
- (i) an antidandruff agent;
- (ii) wax or a wax-like substance in which said antidandruff agent is soluble or dispersible, where melting point of said wax and said substance is 30°C to 105°C and where said substance is not a UV absorbing sunscreen; and,
- (iii) a cationic polymer having weight average molecular weight of 103 Da to 107 Da, where said composite particle has particle size 0.1 to 1000 microns and where said wax-like substance is a C13 to 35 fatty alcohol; where said wax is at least one of beeswax, Chinese wax, lanolin, shellac wax, spermaceti, bayberry wax, candelilla wax, carnauba wax, castor wax, esparto wax, Japan wax, ouricury wax, rice bran wax, soy wax, tallow tree wax, ceresin wax, montan wax, ozocerite or peat wax.
- We have determined that particles of the invention not only serve to deposit more of the antidandruff agent on the scalp but also stabilise the antidandruff agent, especially piroctone olamine, in a haircare product, such as a shampoo composition. Such agents may lose their efficacy over a period presumably due to presence of surfactants, polymers and other ingredients which may degrade or destabilize the antidandruff agent.
- In accordance with a second aspect, disclosed is a method of preparing a composition as claimed in claim 1 comprising a step of heating and agitating an aqueous slurry comprising said wax or wax-like substance and said antidandruff agent, followed by a step of adding said cationic polymer to said slurry and further heating said slurry for 5 to 60 minutes at 30 to 100 °C.
- In accordance with a third aspect is disclosed a hair care product comprising a composition of the first aspect.
- For the avoidance of doubt, any feature of one aspect of the present invention may be utilized in any other aspect of the invention. The word "comprising" is intended to mean "including" but not necessarily "consisting of or "composed of." In other words, the listed steps or options need not be exhaustive. It is noted that the examples given in the description below are intended to clarify the invention and are not intended to limit the invention to those examples per se. Similarly, all percentages are weight/weight percentages unless otherwise indicated. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description and claims indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about". Numerical ranges expressed in the format "from x to y" are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format "from x to y", it is understood that all ranges combining the different endpoints are also contemplated. As used herein, the indefinite article "a" or "an" and its corresponding definite article "the" means at least one, or one or more, unless specified otherwise. The various features of the present invention referred to in individual sections above apply, as appropriate, to other sections mutatis mutandis. Consequently, features specified in one section may be combined with features specified in other sections as appropriate. Any section headings are added for convenience only and are not intended to limit the disclosure in any way.
- By "haircare product" as used herein, is meant to include a composition for topical application to hair or scalp of mammals, especially humans. By topical is meant that the product is applied to the external surface of the body. In the present invention this is achieved by applying the haircare product to hair or scalp. Such a product may be generally classified as leave-on or rinse off, and includes any product applied for improving the appearance, cleansing, odor control or general aesthetics of scalp and hair. The haircare product of the present invention is preferably a leave-on product. Alternatively, the haircare product of the present invention is a wash-off composition. A haircare product in accordance with the present invention is preferably a shampoo, hair conditioner, hair cream, hair colour, hair serum, mousse, hair gel or hair oil.
- In a first aspect, the composite particle of the invention comprises:
- (i) an antidandruff agent;
- (ii) wax or a wax-like substance in which said antidandruff agent is soluble or dispersible, where melting point of said wax and said substance is 30°C to 105°C and where said substance is not a UV absorbing sunscreen; and,
- (iii) a cationic polymer having weight average molecular weight of 103 Da to 107 Da, where said composite particle has particle size 0.1 to 1000 microns and where said wax-like substance is a C13 to 35 fatty alcohol; where said wax is at
least one of beeswax, Chinese wax, lanolin, shellac wax, spermaceti, bayberry wax, candelilla wax, carnauba wax, castor wax, esparto wax, Japan wax, ouricury wax, rice bran wax, soy wax, tallow tree wax, ceresin wax, montan wax, ozocerite or peat wax. - The term particles means particles ranging in size from 0.1 to 1000 µm, preferably from 0.1 to 100 µm, most preferably from 1 to 50 µm. Preferably the composition of the invention is powdery.
- Alternatively, the composition of the invention, i.e., the particles is powdery, preferably a freeze-dried powder. The size may be measured for example, by laser diffraction using a system (such as a Mastersizer™ 2000 available from Malvern Instruments Ltd). It is preferred that ratio of the amount of the antidandruff agent to the amount of said wax or wax-like substance in said microparticles is from 1:0.01 to 1:1000 parts by weight.
- It is preferred that the microparticles comprise 0.1 to 80 wt% antidandruff agent, 18 to 95 wt% of the wax or wax-like substance and 0.5 to 10 wt% cationic polymer.
- The composition of this invention comprises a wax or a wax-like substance in which the antidandruff agent is soluble or dispersible, where melting point of the wax and the substance is 30°C to 105°C. The wax-like substance is not a UV absorbing sunscreen.
- Melting point refers to the temperature at which the solid and liquid forms of a pure substance can exist in equilibrium.
- The wax of the invention is at least one of beeswax, Chinese wax, lanolin, shellac wax, spermaceti, bayberry wax, candelilla wax, carnauba wax, castor wax, esparto wax, Japan wax, ouricury wax, rice bran wax, soy wax, tallow tree wax, ceresin wax, montan wax, ozocerite or peat wax. Such waxes are often selected from hydrocarbon waxes and ester waxes, that can be derived from natural sources or synthesized. Suitable hydrocarbon waxes include mineral wax, microcrystalline wax, Montana wax, and low molecular weight polyethylene, such as from 300 to 600 daltons. Suitable ester waxes can be derived from unsaturated natural oils, such as plant-originating triglyceride oils by hydrogenation and optionally dehydroxylation (where the substituent contains at least one hydroxyl group as in castor oil). Suitable ester waxes include caster wax, candelilla wax, carnauba wax, beeswax and spermeceti wax. Natural waxes such as beeswax include a range of different chemical classes. Synthetic esters often comprise aliphatic monoesters containing at least 30 carbons, and indeed may be isolated natural products such as beeswax, or be derived from them or be the same compounds.
- The wax-like substance of the present invention is a C13-35 fatty alcohol.
- One or a blend of fatty alcohols can be used. Preferred fatty alcohols include cetostearyl alcohol, cetyl alcohol, stearyl alcohol, eicosyl alcohol and behenyl alcohol. Commercial fatty alcohols, though nominally and predominantly one specified alcohol often comprise a minor fraction, such as up to 5 or 6% by weight in total, of homologues differing by 2, 4 or even 6 carbons.
- The wax and the wax-like substance is not a UV absorbing sunscreen. For example, some sunscreens are listed below: 2-hydroxy-4-methoxybenzophenone (also named as Benzophenone-3 CAS: 131-57-7, MP 62 to 64°C), 2,2-dihydroxy-4-methoxybenzophenone (CAS: 131-53-3, MP 73 to 75°C), butylmethoxydibenzoylmethane (CAS: 70356-09-1, MP 81 to 84°C), bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S, CAS: 187393-00-6, MP 83-85°C), Menthyl anthranilate (CAS: 134-09-8, MP 62.5-63.5°C), 4-Methylbenzylidene camphor (Enzacamene) (CAS: 36861-47-9, MP 66 to 69°C), Benzophenone-7 (5-chloro-2-hydroxybenzophenone) (CAS: 85-19-8, MP 96 to 98°C), Benzophenone-8 (dioxybenzone) (CAS: 131-53-3, MP 68°C), Benzophenone-10 (mexenone, 2-hydroxy-4-methoxy-4'-methyl-benzophenone, CAS: 1641-17-4, MP 99 to 102°C), Benzophenone-12 (octabenzone) (CAS: 1843-05-6, MP 47 to 49°C).
- The composition of the invention, i.e., the microparticles, preferably comprise from 0.1 to 80 wt.%, preferably from 0.2 to 40 wt.%, more preferably from 0.25 to 15 wt.% of the antidandruff agent. Antidandruff agents are compounds that are active against dandruff and are typically antimicrobial agents, preferably antifungal agents. Antidandruff agents typically display a minimum inhibitory concentration of about 50 mg/ml or less against Malassezia.
- It is preferred that the anti-dandruff agent is piroctone olamine, climbazole, selenium sulphide, zinc pyrithione, or zinc sulfate.
- The compositions of the invention also comprise a cationic polymer. Preferably the polymer is polyamine, polyvinylpyrrolidone, polylysine, protamine, trimethylammonioethyl (meth)acrylate homopolymer and copolymer, acrylamidopropyl trimethylammonium halide homopolymer and copolymer, dialkyldiallylammonium halide homopolymer and copolymer, chitosan or derivatized chitosan, cellulose derivatives comprising trimethyl ammonium substituted epoxide, starch hydroxypropyl trimethyl ammonium halide, polyethyleneimines or polycondensates containing diquaternary ammonium or polyquaternary ammonium repeating units.
- The term cationic polymer is used to distinguish such polymers from anionic, i.e., negatively charged polymers as well as from non-ionic polymers, i.e., polymers devoid of any charge.
- It is preferred that molecular weight of the cationic polymer is 30,000 to 1,000,000 Daltons, more preferably from 70,000 to 600,000 Daltons, and still even more preferably from 150,000 to 400,000 Daltons.
- Zeta potential is the charge that develops at the interface between a solid surface and its liquid medium. This potential, which is measured in Millivolts, may arise by any of several mechanisms. Among these are the dissociation of ionogenic groups in the particle surface and the differential adsorption of solution ions into the surface region. The net charge at the particle surface affects the ion distribution in the nearby region, increasing the concentration of counterions close to the surface. Thus, an electrical double layer is formed in the region of the particle-liquid interface. Zeta potential is therefore a function of the surface charge of the particle, any adsorbed layer at the interface, and the nature and composition of the surrounding suspension medium. It can be experimentally determined and, because it reflects the effective charge on the particles and is therefore related to the electrostatic repulsion between them, the zeta potential has proven to be extremely relevant to the practical study and control of colloidal stability and flocculation processes. A variety of methods and apparatus are available for its measurement with a reasonable degree of precision. For example, the zeta potential of the particles is measured using a Malvern Nano ZS90 apparatus, in DI water at a solid content of 50 ppm and pH of 7 at 25°C.
- It is preferred that zeta potential of the cationic polymer is from +10 to +100 mV. It is particularly preferred that the polymer is chitosan. It is preferred that the chitosan comprises a chitosan component and an anion. It is preferred that the chitosan is a salt of chitosan and an amino acid. Preferably the amino acid comprises glutamine, glutamic acid, histidine, leucine, lysine, serine, threonine, arginine or a mixture thereof, more preferably arginine.
- Preferably, the chitosan comprises at least 5%, more preferably at least 10% of protonated primary amino group by mole of the total amount of primary amino group and protonated primary amino group.
- It is preferred that degree of deacetylation of chitosan is at least 65%, more preferably from 70 to 95%, even more preferably from 72 to 90% and most preferably from 75 to 85%.
- It is preferred that ratio of the antidandruff agent to the cationic polymer in said microparticles is from 1:0.01 to 1:1000 parts by weight.
- It is preferred that the compositions of the invention, i.e., particles, comprise a co-solvent in which said antidandruff agent is soluble or dispersible, where said co-solvent is a ketone and where said co-solvent is neither wax nor a waxy-like substance. This co-solvent is in addition to the wax or wax-like substance.
- It is preferred said co-solvent is a ketone selected from 2-hexanone or 2-octanone or damascone.
- More preferably this ketone is damascone.
- In accordance with a second aspect is disclosed a method of preparing a composition of the first aspect comprising a step of heating and agitating an aqueous slurry comprising said wax or wax-like substance and said antidandruff agent, followed by a step of adding said cationic polymer to said slurry and further heating said slurry for 5 to 60 minutes at 30 to 100 °C to get the composite particle or a slurry of the composite particle.
- In accordance with a third aspect is disclosed a hair care product comprising a composition of the first aspect. More preferably the haircare product comprises an amount of the composition (i.e., microparticles) such that the total amount of the antidandruff agent in said haircare product is from 0.01 to 5.0 wt%.
- Further preferably the haircare product is a shampoo, hair conditioner, hair cream, hair colour, hair serum, mousse, hair gel or hair oil.
- In addition to the antidandruff agent that is present in the form of the composite particles, the haircare compositions in accordance with this invention may also comprise additional antidandruff agent which may, for example, be the same as the one contained inside the microparticles. Whenever present, the haircare compositions of the invention preferably comprise 0.05 to 5 wt% of additional antidandruff agent. The additional antidandruff agent is preferably selected from azoles, Octopirox® (piroctone olamine), selenium sulfide, salicylic acid and combinations thereof. Azoles include ketoconazole and climbazole, preferably climbazole.
- The haircare compositions of the invention may further comprise a zinc salt. The additional zinc salt may suitably be selected from zinc salts of organic acids, zinc salts of inorganic acids, zinc oxides, zinc hydroxides or a mixture thereof.
- Examples of preferred zinc salts include zinc oxide, zinc pyrrolidone carboxylic acid, zinc citrate, zinc carbonate, zinc chloride, zinc sulphate, zinc glycinate, zinc acetate, zinc lactate, and mixtures thereof. When present, it is preferred that the haircare compositions of the invention comprise 0.1 to 5 wt%, preferably 0.2 to 3 wt%, more preferably from 0.25 to 2.5 wt% of the salt based on the total weight of the composition. The haircare compositions of the present invention comprises a surfactant selected from the group consisting of anionic surfactants, nonionic surfactants, zwitterionic surfactants and mixtures thereof. The nature, type, amount and specific combinations that may be used depend on the formulation of the composition and would largely depend on whether it is a shampoo or a conditioner or a conditioning shampoo.
- Preferably, the haircare product of the invention is a shampoo. Preferably it comprises a surfactant which is sodium lauryl sulphate, sodium lauryl ether sulphate, sodium lauryl ether sulphosuccinate, ammonium lauryl sulphate, ammonium lauryl ether sulphate, sodium cocoyl isethionate and lauryl ether carboxylic acid, coco betaine, cocamidopropyl betaine, sodium cocoamphoacetate or a mixture thereof.
- Preferably, the haircare product of the present invention comprises from 1 to 50%, preferably from 2 to 40%, more preferably from 4 to 25% total surfactant.
- It is further preferred that the haircare product of the invention comprises a cosmetic ingredient. Preferably the cosmetic ingredient is selected from the group consisting of a silicone, an antibacterial agent other than antidandruff agents, a foam booster, a perfume, encapsulates (for example encapsulated fragrance) a dye, a colouring agent, a pigment, a preservative, a thickener, a protein, a phosphate ester, a buffering agent, a pH adjusting agent, a pearlescer (for example; mica, titanium dioxide, titanium dioxide coated mica, ethylene glycol distearate (INCI glycol distearate)) and/or opacifier, a viscosity modifier, an emollient, a sunscreen, an emulsifier, a sensate active (for example menthol and menthol derivatives), vitamins, mineral oils, essential oils, lipids, natural actives, glycerin, natural hair nutrients such as botanical extracts, fruit extracts, sugar derivatives and amino acids, microcrystalline cellulose and mixtures thereof.
- Preferably, the haircare product of the present invention includes from 0.01 to 20 wt% of the at least one cosmetic ingredient, more preferably from 0.05 to 10 wt%, still more preferably from 0.075 to 7.5 wt% and most preferably, from 0.1 to 5 wt% of the at least one cosmetic ingredient, by weight of the total product.
- The haircare product of the present invention may also comprise synergistic antimicrobial compounds that give synergistic antimicrobial benefit when used in combination with the antidandruff active (for example zinc pyrithione) to enhance its properties and further inhibit the growth of Malassezia furfur. Non-limiting examples of these compounds include compounds having alcoholic groups (e.g. honokiol, magnolol or paeonol), Piperazines and a phenolic compound found in natural plant extract viz. thymol and terpeniol.
- The haircare product may additionally comprise a vitamin B3 compound. The preferred vitamin B3 compound is niacinamide.
- Niacinamide is known for secretion of AMPs (Anti-Microbial Proteins) from keratinocytes. The AMPs thus secreted provides for improving immunity of e.g. the scalp. Thus with the use of niacinamide, the anti-dandruff efficacy can be enhanced not just through anti-fungal activity but by boosting the scalp's own protection shield against germs, through use of niacinamide. This combination could provide further long-lasting protection e.g. up to 24 hours of protection against germs.
- When present, it is preferred that the haircare compositions of the invention comprise 0.1 to 5% niacinamide, more preferably 0.5 to 5%, furthermore preferably 0.5 to 3%, and optimally 1.0 to 3.0% by weight of the composition.
- It is preferred that the haircare product of the invention comprises silicone.
- For example, the compositions of the invention may contain emulsified droplets of a silicone conditioning agent for enhancing conditioning performance.
- Suitable silicones include polydiorganosiloxanes, polydimethylsiloxanes which have the CTFA designation dimethicone. In addition, suitable for use in the compositions of the invention (particularly shampoos and conditioners) are polydimethyl siloxanes having hydroxyl end groups, which have the CTFA designation dimethiconol.
- Preferably the viscosity of the emulsified silicone is at least 10,000 cst at 25 °C, the viscosity of the silicone is preferably at least 60,000 cst, most preferably at least 500,000 cst, ideally at least 1,000,000 cst. Preferably the viscosity does not exceed 109 cst for ease of formulation.
- Examples of suitable pre-formed emulsions include Xiameter MEM 1785 and microemulsion DC2-1865 available from Dow Corning. These are emulsions /microemulsions of dimethiconol. Cross-linked silicone gums are also available in a pre-emulsified form, which is advantageous for ease of formulation. A further preferred class of silicones for inclusion in shampoos and conditioners are amino functional silicones. By "amino functional silicone" is meant a silicone containing at least one primary, secondary or tertiary amine group, or a quaternary ammonium group. Examples of suitable amino functional silicones include: polysiloxanes having the CTFA designation "amodimethicone".
- Specific examples of amino functional silicones suitable for use in the invention are the aminosilicone oils DC2-8220, DC2-8166 and DC2-8566 (all ex Dow Corning).
- It is preferred that the total amount of silicone is 0.01 to 10 %wt, more preferably 0.1 to 5 wt% and most preferably 0.5 to 3 wt%.
- It is preferred that pH of the haircare product of the present invention is preferably from 3 to 7, more preferably 4 to 7, even more preferably 4 to 6.5, most preferably from 4.2 to 6.5.
- When the haircare product of the invention is a shampoo, it is generally aqueous, i.e. they have water or an aqueous solution or a lyotropic liquid crystalline phase as their major component.
- Suitably, the shampoo composition comprises 50 to 98%, preferably from 60 to 92% water.
- Preferably the shampoo composition comprises one or more cationic polymers for conditioning the hair.
- Suitable cationic polymers include homopolymers which are cationically substituted or may be formed from two or more types of monomers. The weight average (Mw) molecular weight of the polymers will generally be between 100000 and 3 Million Daltons. The polymers will have cationic nitrogen containing groups such as quaternary ammonium or protonated amino groups, or a mixture thereof. If the molecular weight of the polymer is too low, then the conditioning effect is poor. If too high, then there may be problems of high extensional viscosity leading to stringiness of the composition when it is poured.
- The cationic nitrogen-containing group will generally be present as a substituent on a fraction of the total monomer units of the cationic polymer. Thus, when the polymer is not a homopolymer it can contain spacer non-cationic monomer units. Such polymers are described in the CTFA Cosmetic Ingredient Directory, 3rd edition. The ratio of the cationic to non-cationic monomer units is selected to give polymers having a cationic charge density in the required range, which is generally from 0.2 to 3.0 meq/gm. The cationic charge density of the polymer is suitably determined via the Kjeldahl method as described in the US Pharmacopoeia under chemical tests for nitrogen determination.
- Suitable cationic polymers include copolymers of vinyl monomers having cationic amine or quaternary ammonium functionalities with water soluble spacer monomers such as (meth)acrylamide, alkyl and dialkyl (meth)acrylamides, alkyl (meth)acrylate, vinyl caprolactone and vinyl pyrrolidine. The alkyl and dialkyl substituted monomers preferably have C1-C7 alkyl groups, more preferably C1-3 alkyl groups. Other suitable spacers include vinyl esters, vinyl alcohol, maleic anhydride, propylene glycol and ethylene glycol.
- The cationic amines can be primary, secondary or tertiary amines, depending upon the particular species and the pH of the composition. In general, secondary and tertiary amines, especially tertiary, are preferred.
- Amine substituted vinyl monomers and amines can be polymerised in the amine form and then converted to ammonium by quaternization.
- The cationic polymers can comprise mixtures of monomer units derived from amine- and/or quaternary ammonium-substituted monomer and/or compatible spacer monomers.
- Suitable (non-limiting examples of) cationic polymers include:
- cationic diallyl quaternary ammonium-containing polymers including, for example, dimethyldiallylammonium chloride homopolymer and copolymers of acrylamide and dimethyldiallylammonium chloride, referred to in the industry (CTFA) as Polyquaternium 6 and Polyquaternium 7, respectively;
- mineral acid salts of amino-alkyl esters of homo-and co-polymers of unsaturated carboxylic acids having from 3 to 5 carbon atoms, (as described in
U.S. Patent 4,009,256 ); - cationic polyacrylamides (as described in
WO95/22311 - Other cationic polymers that can be used include cationic polysaccharide polymers, such as cationic cellulose derivatives, cationic starch derivatives, and cationic guar gum derivatives.
- A particularly suitable type of cationic polysaccharide polymer that can be used is a cationic guar gum derivative, such as guar hydroxypropyltrimethylammonium chloride (commercially available from Rhodia in their JAGUAR trademark series). Examples of such materials are JAGUAR C13S, JAGUAR C14 and JAGUAR C17.
- Mixtures of any of the above cationic polymers may be used.
- It is preferred that the haircare product of the invention comprises 0.01 to 5%, preferably from 0.02 to 1%, more preferably from 0.05 to 0.8% cationic polymer.
- The haircare product of the invention may additionally comprise a cationic deposition polymer which is a cationic polygalactomannans having an average molecular weight (Mw ) of from 1 million to 2.2 million g/mol and a cationic degree of substitution of from 0.13 to 0.3.
- The polygalactomannans are polysaccharides composed principally of galactose and mannose units and are usually found in the endosperm material of seeds from leguminous plants such as guar, locust bean, honey locust, flame tree, and other members of the Leguminosae family. Polygalactomannans are composed of a backbone of 1→4-linked β-D-mannopyranosyl main chain units (also termed mannoside units or residues) with recurring 1→6-linked α-D-galactosyl side groups (also termed galactoside units or residues) branching from the number 6 carbon atom of a mannopyranose residue in the polymer backbone. The polygalactomannans of the different Leguminosae species differ from one another in the frequency of the occurrence of the galactoside side units branching from the polymannoside backbone. The mannoside and galactoside units are generically referred to herein as glycoside units or residues. The average ratio of mannoside to galactoside units in the polygalactomannan contained in guar gum (hereinafter termed "guar") is approximately 2:1.
- Suitable cationic polygalactomannans include guar and hydroxyalkyl guar (for example hydroxyethyl guar or hydroxypropyl guar), that has been cationically modified by chemical reaction with one or more derivatizing agents.
- In a typical composition the amount of cationic polygalactomannans will generally range from about 0.05 to 1%, preferably from 0.1 to 0.8%, more preferably 0.2 to 0.6% by weight of the composition.
- The haircare product of the invention may additionally comprise an anionic polymeric rheology modifier such as a carboxylic acid polymer.
- The term "carboxylic acid polymer" in the context of this invention generally denotes a homopolymer or copolymer obtained from the polymerization of ethylenically unsaturated monomers containing pendant carboxylic acid groups (hereinafter termed "carboxylic monomers").
- Suitable carboxylic monomers generally have one or two carboxylic acid groups, one carbon to carbon double bond and contain a total of from 3 to about 10 carbon atoms, more preferably from 3 to about 5 carbon atoms.
- Specific examples of suitable carboxylic monomers include α-β-unsaturated monocarboxylic acids such as acrylic acid, methacrylic acid and crotonic acid; and α-β-unsaturated dicarboxylic acids such as itaconic acid, fumaric acid, maleic acid and aconitic acid. Salts, esters or anhydrides of the α-β-unsaturated mono- or dicarboxylic acids described above may also be used. Examples include half esters of α-β-unsaturated dicarboxylic acids with C1-4 alkanols, such as monomethyl fumarate; cyclic anhydrides of α-β-unsaturated dicarboxylic acids such as maleic anhydride, itaconic anhydride and citraconic anhydride; and esters of acrylic acid or methacrylic acid with C1-30 alkanols, such as ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, dodecyl acrylate, hexadecyl acrylate, and octadecyl acrylate.
- Optionally, other ethylenically unsaturated monomers can be copolymerized into the carboxylic acid polymer backbone. Example of such other ethylenically unsaturated monomers include styrene, vinyl acetate, ethylene, butadiene, acrylonitrile and mixtures thereof. Carboxylic acid polymers may preferably have a molecular weight of at least 1 million Daltons.
- Suitable examples include crosslinked copolymers polymerized from C1-4 alkyl acrylate or methacrylate (e.g. ethyl acrylate) with one or more comonomers selected from acrylic acid, methacrylic acid and mixtures thereof. Such materials may generally be referred to under the INCI name of Acrylates Copolymer. Commercially available examples include Aculyn® 33 from Rohm and Haas.
- Also suitable are crosslinked copolymers polymerized from C10-30 alkyl esters of acrylic or methacrylic acid with one or more comonomers selected from acrylic acid, methacrylic acid and their respective C1-4 alkyl esters. Such materials may generally be referred to under the INCI name of Acrylates/C 10-30 Alkyl Acrylate Crosspolymer. Commercially available examples include Carbopol® polymers 1342 and 1382 from Lubrizol Advanced Materials.
- Also suitable are optionally crosslinked copolymers of acrylic acid or methacrylic acid with alkyl acrylates and ethoxylated hydrophobically modified alkyl acrylates. Such materials may generally be referred to under the INCI names of Acrylates/Steareth-20 Methacrylate Copolymer, Acrylates/Beheneth-25 Methacrylate Copolymer, Acrylates/Steareth-20 Methacrylate Crosspolymer and Acrylates/Palmeth-25 Acrylates Copolymer. Commercially available examples include Aculyn® 22, 28 or 88 from Rohm & Haas and Synthalen® from 3V Sigma.
- It is preferred that the carboxylic acid is a Carbomer, such as homopolymers of acrylic acid crosslinked with an allyl ether of pentaerythritol or an allyl ether of sucrose.
- Mixtures of any of the aforementioned material may also be used.
- Preferably haircare product of the invention comprises 0.1 to 3.0%, more preferably 0.4 to 1.5% carboxylic acid polymer by weight of the composition.
- In formulations containing anionic polymeric rheology modifiers such as the carboxylic acid polymers described above, it is often necessary to neutralize at least a portion of the free carboxyl groups by the addition of an inorganic or organic base. Examples of suitable inorganic or organic bases include alkali metal hydroxides (e.g. sodium or potassium hydroxide), sodium carbonate, ammonium hydroxide, methylamine, diethylamine, trimethylamine, monoethanolamine, triethanolamine and mixtures thereof.
- The haircare product of the invention may also comprise a nonionic polymeric rheology modifier which is selected from one or more nonionic cellulose ethers.
- Suitable nonionic cellulose ethers or use as the nonionic polymeric rheology modifier in the invention include (C1-3 alkyl) cellulose ethers, such as methyl cellulose and ethyl cellulose; hydroxy (C1-3 alkyl) cellulose ethers, such as hydroxyethyl cellulose and hydroxypropyl cellulose; mixed hydroxy (C1-3 alkyl) cellulose ethers, such as hydroxyethyl hydroxypropyl cellulose; and (C1-3 alkyl) hydroxy (C1-3 alkyl) cellulose ethers, such as hydroxyethyl methylcellulose and hydroxypropyl methylcellulose. Preferred nonionic cellulose ethers for use as the nonionic polymeric rheology modifier in the invention are water-soluble nonionic cellulose ethers such as methylcellulose and hydroxypropyl methylcellulose. The term "water-soluble" in this context denotes a solubility in water of at least 1 grams, more preferably at least 3 grams, most preferably at least 5 grams in 100 grams of distilled water at 25° C. and 1 atmosphere. This level indicates production of a macroscopically isotropic or transparent, coloured or colourless solution.
- Methyl cellulose and hydroxypropyl methylcellulose are commercially available in a number of viscosity grades from Dow Chemical as their METHOCEL® trademark series.
- Mixtures of any nonionic cellulose ethers may also be suitable. In a typical composition according to the invention the level of nonionic cellulose ethers will generally range from about 0.01 to about 2.0%, and preferably ranges from 0.1 to 0.5%, more preferably from 0.1 to 0.3%, by weight based on the total weight of the composition.
- Preferably the haircare product of the invention comprises 0.1 to 0.3% by weight nonionic cellulose ether.
- The haircare product of the invention may contain further optional ingredients to enhance performance and/or consumer acceptability. Examples of such ingredients include fragrance, dyes and pigments and preservatives. Each of these ingredients will be present in an amount effective to accomplish its purpose. Generally, these optional ingredients are included individually at a level of up to 5% by weight based on the total weight of the composition.
- The haircare product of the invention is primarily intended for topical application to hair and scalp.
- When the haircare product is a shampoo, it is topically applied to the hair and then massaged into the hair and scalp. Then it is rinsed with water prior to drying the hair. A hair oil or hair serum, being leave-on haircare compositions, are left on for 1 to 10 hours after application before being washed off.
- The invention will be further illustrated by the following, non-limiting Examples, in which all percentages quoted are by weight based on total weight unless otherwise stated.
- The invention is not limited to the embodiments illustrated in the drawings. Accordingly, it should be understood that where features mentioned in the claims are followed by reference numerals, such numerals are included solely for the purpose of enhancing the intelligibility of the claims and are in no way limiting to the scope of the claims. The examples are intended to illustrate the invention and are not intended to limit the invention to those examples per se.
- A gram of Octopirox® was dissolved in 12.5 g molten cetostearyl alcohol to form clear solution at 70°C. Thereafter 86.5 g DI water was taken in a 250 mL beaker and heated to 70°C with agitation. The Octopirox® solution in cetostearyl alcohol was added to the water under homogenizing at 2000 rpm for 15 minutes. The system was cooled gradually to room temperature under stirring. Then evaporated water was complemented until 100 g slurry was left behind (13.5 % solids content, i.e. microparticles). The particle size of the microparticles was 70 µm.
- Three grams chitosan was dissolved in 300 mL of 0.5% aqueous acetic acid to form 1% chitosan solution. A gram of Octopirox® was dissolved in 12.5 g molten cetostearyl alcohol to form a clear solution at 70°C.
- Thereafter 62.5 g of the 1% chitosan acetate solution and 24 g of the DI water were mixed in a beaker at 70°C. The Octopirox® solution was heated to 70°C and added to the contents of the beaker under homogenizing at 2000 rpm for 15 minutes. The system was cooled gradually to room temperature under stirring. Then evaporated water was complemented until 100 g slurry was left behind (14 % solids content, i.e. microparticles). The particle size of the microparticles was 54 µm.
- A 1% solution of chitosan acetate was prepared as disclosed earlier. A gram of Octopirox® was dissolved in 12.5 g molten cetostearyl alcohol and 4 g damascone to form a clear solution at 70°C.
- Thereafter 62.5 g of the 1% chitosan acetate solution and 20 g DI water were mixed in a beaker at 70°C. The Octopirox® solution was heated to 70°C and added to the contents of the beaker under homogenizing at 2000 rpm for 15 minutes. The system was cooled gradually to room temperature under stirring. Then evaporated water was complemented until 100 g aqueous slurry was left behind (18% solids content, i.e. microparticles).
- The particle size of the microparticles was 43 µm.
- A 1% solution of chitosan acetate was prepared as disclosed earlier. A gram of Octopirox® was dissolved in 8.5 g molten cetostearyl alcohol and 4 g damascone to form a clear solution at 70°C.
- Thereafter 62.5 g of the 1% chitosan solution and 24 g DI water were mixed in a beaker 70°C. The Octopirox® solution was heated to 70°C and added to the beaker under homogenizing at 2000 rpm for 15 minutes. The system was cooled gradually to room temperature under stirring. Then evaporated water was complemented until 100 g slurry was left behind (14% solids content, i.e. microparticles). The particle size of the microparticles was 36 microns.
- Details of the compositions of Examples 1 to 4 is summarised Table 1.
Table 1 Example/wt% Octopirox® Cetostearyl alcohol Damascone Chitosan 1 7.4 92.6 -- -- 2 7.1 88.5 -- 4.4 3 5.5 69.0 22.1 3.4 4 7.1 60.2 28.3 4.4 - The compositions of Examples 1 to 4 were subjected to a variety of tests which are described hereinafter.
- The extent of deposition (on scalp) of Octopirox® contained in the microparticles was evaluated by formulating a series of shampoo compositions 1A to 4A, each comprising a fixed amount of the microparticles from examples 1 to 4. In other words, shampoo 1A contained microparticles of Example 1 and so on.
- The formulations are shown in Table 2.
Table 2 Ingredients/wt% Example Reference No. 1A 2A 3A 4A 5 Octopirox® - - - - 0.2 Example 1 20 - - - - Example 2 - 20 - - - Example 3 - - 20 - - Example 4 - - - 20 - SLES (70%) 17.0 CAPB (30%) 5.0 Sodium chloride 1.0 - The extent of deposition of Octopirox® on the scalp was determined as follows:
A piece of model skin (2cm x 2cm x 4mm) was placed in a Petridish®, to which 375 mg of the concerned shampoo (under evaluation) has been added. That piece and another blank piece (untreated) were then immersed in 10 ml methanol and dispersed with 10 minutes of ultrasonic treatment. An ml of the methanolic solution was passed through a 0.2 µm PTFE filter and transferred into Liquid Chromatography (LC) sample vial for LC analysis to get deposition amount data D0. - A piece of model skin (2cm x 2cm x 4mm) was placed in a Petridish®, to which 375 mg of the concerned shampoo (under evaluation) has been added. That piece of shampoo on it was then gently rubbed with another piece (untreated) for 30 seconds and the two pieces were rinsed by 250 mL water. The rinsed pieces were then immersed in 10 ml methanol and dispersed with 10 minutes of ultrasonic treatment. An ml of the methanolic solution was passed through a 0.2 µm PTFE filter and transferred into Liquid Chromatography (LC) sample vial for LC analysis to get deposition amount data D.
-
- The data is summarised in Table 3.
Table 3 Sample Reference number % Deposition Example 5 1.9 Example 1A 9.4 Example 2A 31.1 Example 3A 28.3 Example 4A 22.1 - The data in Table 3 indicates that the % deposition provided by a composition (microparticles) outside the invention (Example 5 and 1A) is not as good as the extent of deposition that was observed in the case of Examples 2A-4A.
- The objective of this experiment was to determine the extent of stability of Octopirox® contained in the microparticles of Examples 1 to 4 in a shampoo composition. It was evaluated by checking how much Octopirox® contained within the microparticles leaked into the shampoo base. For this test the shampoo products 5 and 1A to 4A were used immediately after preparation. The test was repeated after storing the compositions for 1 day, 7 days and 14 days.
- For this experiment the shampoo products were made by mixing four grams of the slurry of the microparticles (Example 1 to 4 as the case may be) with 16 g of a shampoo base in 50 mL centrifuge tubes. Therefore, the formulations of the shampoos for the purpose of this experiment were different from the formulations (1A to 4A) disclosed in Table 2. To avoid confusion with nomenclature, the sample reference numbers used for this experiment were labelled as 1B to 4B.
- Samples of the shampoos were stored at room temperature for a period of 1-day, 7-days and 14-days. At the predetermined time, 20 g deionized water was added into the centrifuge tube (containing 20 g shampoo) and the tubes were centrifuged at 10000 rpm for 20 minutes. Then the liquid part (supernatant) was collected for UV analysis to find out the concentration of Octopirox® in it which is represented as the % loss as compared to the amount of Octopirox® in a freshly prepared shampoo product.
- The results are summarised in Table 4.
Table 4 Sample Reference No. Leakage/loss of Octopirox® 1-day 7-day 14-day 1B 90.0 100.0 -- 2B 35.1 78.2 100.0 3B 15.4 45.6 70.4 4B 17.4 38.9 40.8 - The data in Table 4 indicates that Octopirox was more stable in the case of compositions 2B to 4B. However, from among these three, the stability was the highest in the case of Example 4B. The microparticles of Example 4 contained a co-solvent (damascene) and this additional stability (or reduced leakage) can be attributed to damascone.
- For this experiment, the slurry of Example 4 was freeze-dried to get a powder. Seven (7) mg of this powder was incubated in 2 mL of a model sebum composition in an oven maintained at 32°C. At a predetermined time, the mixture was taken out of the oven and passed through a 0.2 µm PTFE filter to remove any insoluble matter. The filtrate was dispersed in methanol and transferred into a LC sample vial for LC analysis. Another 7 mg of the same powder was dissolved directly in methanol and the concentration of Octopirox® was measured by LC. This sample was for comparative purpose (control) and was for 100% release sample. Then the percentage of Octopirox® getting released from the composite was calculated.
- The results showed that about 90% of the Octopirox® was released from the composite of Example 4 into sebum at 32°C. In other words, this observation indicates that a composite in accordance with the invention is stable enough inside the composition but at the same time, the composite is capable of releasing the Octopirox® when in contact with sebum, and this property renders it suitable for use in haircare products like a shampoo.
- A 1% solution of chitosan acetate was prepared as disclosed earlier. A gram of Octopirox® was dissolved in 8.5 g molten lauryl alcohol (MP 24°C) and 4 g damascone to form a clear solution at 40°C.
- Thereafter 62.5 g of the chitosan acetate solution and 24 g DI water were measured in a beaker at 40°C. The Octopirox® solution was heated to 40°C and added to the beaker under homogenizing at 2000 rpm for 15 minutes. The system was cooled gradually to room temperature under stirring. Thereafter, the evaporated water was complemented to get 100 g of an aqueous slurry.
- It was possible to prepare microparticles by this method but when the temperature increased above 24°C, the composite turned into a liquid indicating that the microparticles were not heat-stable.
- A 1% solution of chitosan acetate was prepared as disclosed earlier.
- A gram of Octopirox® was dissolved in 8.5 g molten Fischer-Tropsch wax (Sasolwax® H1, MP 112°C) and 4 g damascone to form a clear solution at 120°C.
- Thereafter 62.5 g of the 1% chitosan solution and 20 g DI water were measured in a beaker at 100°C. The Octopirox® solution was heated to 120°C and added to the beaker under homogenizing at 2000 rpm. The Octopirox® solution solidified immediately and failed to form fine composite particles.
Claims (12)
- A composite particle comprising:(i) an antidandruff agent;(ii) a wax or a wax-like substance in which said antidandruff agent is soluble or dispersible, where melting point of said wax and said substance is 30°C to 105°C; and,(iii) a cationic polymer having weight average molecular weight of 103 Da to 107 Da,where said composite particle has particle size 0.1 to 1000 µm and where said wax-like substance is a C13 to 35 fatty alcohol; where said wax is at least one of beeswax, Chinese wax, lanolin, shellac wax, spermaceti, bayberry wax, candelilla wax, carnauba wax, castor wax, esparto wax, Japan wax, ouricury wax, rice bran wax, soy wax, tallow tree wax, ceresin wax, montan wax, ozocerite or peat wax.
- A composite particle as claimed in claim 1 wherein said composite particle comprises 0.1 to 80 wt% antidandruff agent, 18 to 95 wt% of the wax or wax-like substance and 0.5 to 10 wt% cationic polymer.
- A composite particle as claimed in claim 1 or 2 further comprising a co-solvent in which said antidandruff agent is soluble or dispersible, where said co-solvent is a ketone and where said co-solvent is neither wax nor a wax-like substance.
- A composite particle as claimed in claim 3 wherein said co-solvent is a ketone selected from 2-hexanone, 2-octanone or damascone.
- A composite particle as claimed in claim 3 or 4 wherein said composite particle comprises 0.2 to 30 wt% of said co-solvent.
- A composite particle as claimed in any of claims 1 to 5 wherein zeta potential of said cationic polymer is from +10 to +100 mV.
- A composite particle as claimed in any of claims 1 to 6 wherein said cationic polymer is one or more of polyamine, polyvinylpyrrolidone, polylysine, protamine, trimethylammonioethyl (meth)acrylate homopolymers and copolymers, acrylamidopropyl trimethylammonium halide homopolymers and copolymers, dialkyldiallylammonium halide homopolymers and copolymers, chitosan or derivatized chitosan, cellulose derivatives comprising trimethyl ammonium substituted epoxide, starch hydroxypropyl trimethyl ammonium halide, polyethyleneimines or polycondensates containing diquatemary ammonium or polyquatemary ammonium repeating units.
- A composite particle as claimed in any of claims 1 to 7 wherein said antidandruff agent is piroctone olamine.
- A composite particle as claimed in any of claims 1 to 8 wherein said composite particle is powdery.
- A method of preparing a composite particle as claimed in claim 1 comprising a step of heating and agitating an aqueous slurry comprising said wax or wax-like substance and said antidandruff agent, followed by a step of adding said cationic polymer to said slurry and further heating said slurry for 5 to 60 minutes at 30 to 100 °C to get the composite particle or a slurry of the composite particle.
- A haircare product comprising a composite particle as claimed in any of claims 1 to 9.
- A haircare product as claimed in claim 11 wherein said haircare product comprises an amount of said composite particle as claimed in any of claims 1 to 9 such that the total amount of the antidandruff agent in said haircare product is from 0.01 to 5.0 wt%.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019095311 | 2019-07-09 | ||
EP19193269 | 2019-08-23 | ||
PCT/EP2020/067359 WO2021004770A1 (en) | 2019-07-09 | 2020-06-22 | Hair care composition comprising antidandruff agent |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3996663A1 EP3996663A1 (en) | 2022-05-18 |
EP3996663B1 true EP3996663B1 (en) | 2024-08-07 |
Family
ID=71096723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20733316.2A Active EP3996663B1 (en) | 2019-07-09 | 2020-06-22 | Hair care composition comprising antidandruff agent |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220257477A1 (en) |
EP (1) | EP3996663B1 (en) |
JP (1) | JP2022541738A (en) |
CN (1) | CN114072125B (en) |
BR (1) | BR112021024065A2 (en) |
WO (1) | WO2021004770A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112691049B (en) * | 2021-01-15 | 2022-08-02 | 拉芳家化股份有限公司 | Shampoo composition containing zinc hyaluronate |
WO2024084487A1 (en) * | 2022-10-19 | 2024-04-25 | Sharon Personal Care Ltd. | Vitamin b3 based preservative compositions |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4009256A (en) | 1973-11-19 | 1977-02-22 | National Starch And Chemical Corporation | Novel shampoo composition containing a water-soluble cationic polymer |
WO1995022311A1 (en) | 1994-02-18 | 1995-08-24 | Unilever Plc | Personal washing compositions |
US5624666A (en) * | 1995-01-20 | 1997-04-29 | The Procter & Gamble Company | Anti-dandruff shampoos with particulate active agent and cationic polymer |
US6017860A (en) * | 1996-04-15 | 2000-01-25 | Stepan Company | Cleaning, conditioning and styling hair care compositions |
GB9624874D0 (en) | 1996-11-29 | 1997-01-15 | Unilever Plc | Composition |
US6042792A (en) * | 1997-09-18 | 2000-03-28 | International Flavors & Fragrances Inc. | Apparatus for preparing a solid phase microparticulate composition |
US6355261B1 (en) * | 1999-12-02 | 2002-03-12 | The C. P. Hall Company | Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
US9381382B2 (en) * | 2002-06-04 | 2016-07-05 | The Procter & Gamble Company | Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a gel network |
US20040213751A1 (en) * | 2003-03-18 | 2004-10-28 | Schwartz James Robert | Augmentation of pyrithione activity or a polyvalent metal salt of pyrithione activity by zinc-containing layered material |
DE202004002471U1 (en) * | 2004-02-18 | 2004-04-22 | Wella Ag | Hair treatment agent with terpolymer of vinyl pyrrolidone, methacrylamide and vinyl imidazole and active ingredients |
DE102005028385A1 (en) * | 2005-06-20 | 2006-12-28 | Wella Aktiengesellschaft | Product release system, useful to atomize a cosmetic composition for hair treatment, has pressure-resistant packaging; a spray head containing a capillary; and a propellant-containing cosmetic composition |
US20080020057A1 (en) * | 2006-07-18 | 2008-01-24 | Michael Frederick Niebauer | Personal care composition containing microemulsified wax particles |
ES2397538T3 (en) * | 2007-02-21 | 2013-03-07 | Rovi Cosmetics International Gmbh | Nanoparticles for use in cosmetic and dermatological formulations |
DE102008050430A1 (en) * | 2008-10-08 | 2010-04-15 | Henkel Ag & Co. Kgaa | Anti-dandruff and anti-relapse shampoo |
GB0904700D0 (en) | 2009-03-19 | 2009-04-29 | Unilever Plc | Improvements relating to benefit agent delivery |
CA2850039C (en) * | 2011-10-07 | 2017-03-07 | The Procter & Gamble Company | Shampoo composition containing a gel network |
CA2850025C (en) * | 2011-10-07 | 2018-06-05 | The Procter & Gamble Company | Personal care compositions comprising a cationic guar polymer and a cationic acrylamide polymer |
WO2014060405A2 (en) * | 2012-10-15 | 2014-04-24 | L'oreal | Aqueous wax dispersions and hair styling compositions containing them |
JP6141458B2 (en) | 2013-02-08 | 2017-06-07 | ザ プロクター アンド ギャンブル カンパニー | Hair care composition comprising a cationic polymer and anionic particles |
AU2014252157B2 (en) * | 2013-04-12 | 2017-05-11 | Vyome Therapeutics Limited | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
KR101814895B1 (en) * | 2013-06-04 | 2018-01-04 | 바이옴 바이오사이언스 피브이티. 엘티디. | Coated particles and compositions comprising same |
CN106068143A (en) * | 2013-12-23 | 2016-11-02 | 路博润先进材料公司 | Suspending agent and stabilizer for anti-dandruff Haircare composition |
US10806688B2 (en) * | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
BR112019001802B1 (en) * | 2016-08-19 | 2022-03-03 | Unilever Ip Holdings B.V. | Synergistic antimicrobial composition and use of the composition |
-
2020
- 2020-06-22 BR BR112021024065A patent/BR112021024065A2/en unknown
- 2020-06-22 CN CN202080048323.1A patent/CN114072125B/en active Active
- 2020-06-22 WO PCT/EP2020/067359 patent/WO2021004770A1/en active Search and Examination
- 2020-06-22 EP EP20733316.2A patent/EP3996663B1/en active Active
- 2020-06-22 US US17/625,446 patent/US20220257477A1/en active Pending
- 2020-06-22 JP JP2022500696A patent/JP2022541738A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021004770A1 (en) | 2021-01-14 |
EP3996663A1 (en) | 2022-05-18 |
CN114072125B (en) | 2024-03-26 |
JP2022541738A (en) | 2022-09-27 |
BR112021024065A2 (en) | 2022-01-18 |
CN114072125A (en) | 2022-02-18 |
US20220257477A1 (en) | 2022-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3996663B1 (en) | Hair care composition comprising antidandruff agent | |
US11826453B2 (en) | Hair care composition comprising piroctone olamine | |
EP3377180B1 (en) | Climbazole microcapsule and hair care composition comprising surfactant and climbazole | |
CN115279485B (en) | Microcapsules and cosmetic compositions comprising the same | |
EP3897863B1 (en) | Hair care composition comprising pyrithione | |
EP3703646B1 (en) | Antidandruff composition and method of use | |
RU2816233C2 (en) | Hair care composition comprising an antidandruff agent | |
RU2824000C1 (en) | Microcapsules and cosmetic compositions containing thereof | |
RU2780623C1 (en) | Hair care composition containing pyrithione | |
RU2804357C2 (en) | Hair care composition containing piroctonolamin | |
WO2022089892A1 (en) | Hair care composition | |
CN116568277A (en) | Anti-dandruff composition comprising piroctone olamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211206 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220720 |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20240429 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Free format text: CASE NUMBER: APP_41715/2024 Effective date: 20240716 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602020035314 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |